PMID- 30611579
OWN - NLM
STAT- MEDLINE
DCOM- 20191216
LR  - 20191217
IS  - 1532-8171 (Electronic)
IS  - 0735-6757 (Linking)
VI  - 37
IP  - 4
DP  - 2019 Apr
TI  - Analysis of current financial relationships between emergency physicians and 
      industry.
PG  - 722-725
LID - S0735-6757(18)31001-5 [pii]
LID - 10.1016/j.ajem.2018.12.039 [doi]
AB  - OBJECTIVE: Characterize the frequency and magnitude of all categories of publicly 
      reported financial payments made to emergency physicians (EPs) in the United 
      States (U.S.) in 2017. METHODS: This cross-sectional study of the 2017 Centers 
      for Medicare and Medicaid Services Open Payments Database was exempt from 
      Institutional Review Board Review. We calculated descriptive statistics of the 
      frequency, type, and amount (medians) of general, research, and ownerships 
      transactions made to EPs from industry, described regional differences of median 
      payments to EPs, and characterized the drugs or devices most commonly associated 
      with transactions. RESULTS: In 2017, among 40,899 practicing U.S. EPs, 14,447 
      (35.4%) received 51,870 general payments from industry totaling $12,870,832. The 
      median per-physician payment was $18.30 (interquartile range [IQR], 
      $13.63-$60.90). The most frequent transaction was food and beverage (89.6%), 
      though most payments by dollar amount were related to speaker and consulting fees 
      (74.5%). Antithrombotics were the most frequently drug or device associated with 
      transactions. Only 35 (0.08%) and 20 (0.05%) EPs had research and ownership 
      relationships with industry, respectively. A significant difference was observed 
      in median payments per physician across all U.S. Census regions (p < 0.01) except 
      when comparing Northeast and West (p = 1.00). CONCLUSIONS: Over one-third of U.S. 
      EPs had general payments from industry in 2017, while <1% of EPs had either 
      research and ownership payments during this time period. Consistent with previous 
      research, most payments to EPs are of low monetary value. Antithrombotics remain 
      the most frequent drug associated with payments to EPs.
CI  - Copyright (c) 2018 Elsevier Inc. All rights reserved.
FAU - Niforatos, Joshua D
AU  - Niforatos JD
AD  - Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States. 
      Electronic address: jxn187@case.edu.
FAU - Boas, Samuel
AU  - Boas S
AD  - Case Western Reserve University School of Medicine, Cleveland, OH, United States.
FAU - Hertz, Samuel
AU  - Hertz S
AD  - Case Western Reserve University School of Medicine, Cleveland, OH, United States.
FAU - Ozgur, Ahmed
AU  - Ozgur A
AD  - Koc University School of Medicine, Istanbul, Turkey.
FAU - Raja, Ali S
AU  - Raja AS
AD  - Department of Emergency Medicine, Massachusetts General Hospital/Harvard Medical 
      School, Boston, MA, United States.
LA  - eng
PT  - Journal Article
DEP - 20181229
PL  - United States
TA  - Am J Emerg Med
JT  - The American journal of emergency medicine
JID - 8309942
SB  - IM
MH  - Centers for Medicare and Medicaid Services, U.S.
MH  - Conflict of Interest
MH  - Disclosure/*legislation & jurisprudence
MH  - Drug Industry/economics
MH  - Economics, Medical
MH  - Emergency Medicine/*economics
MH  - Gift Giving
MH  - Humans
MH  - Industry/*economics
MH  - Medicine
MH  - Patient Protection and Affordable Care Act
MH  - Physicians/*economics
MH  - Reimbursement Mechanisms
MH  - United States
EDAT- 2019/01/07 06:00
MHDA- 2019/12/18 06:00
CRDT- 2019/01/07 06:00
PHST- 2018/12/03 00:00 [received]
PHST- 2018/12/19 00:00 [revised]
PHST- 2018/12/19 00:00 [accepted]
PHST- 2019/01/07 06:00 [pubmed]
PHST- 2019/12/18 06:00 [medline]
PHST- 2019/01/07 06:00 [entrez]
AID - S0735-6757(18)31001-5 [pii]
AID - 10.1016/j.ajem.2018.12.039 [doi]
PST - ppublish
SO  - Am J Emerg Med. 2019 Apr;37(4):722-725. doi: 10.1016/j.ajem.2018.12.039. Epub 
      2018 Dec 29.